Tag: Uro-oncology
EMUC20 is now a Virtual Congress!
In a change for uro-oncology experts across Europe, the 12th European Multidisciplinary Congress on Urological Cancers (EMUC20) is now a two-day virtual congress. While the organisers had hoped that the EMUC congress could be held physically like every year, the...
Two recipients of the EAU RF seeding grant set to start new projects
Earlier this year, the EAU’s Research Foundation (EAU RF) announced the availability of two new grants for short-term studies, so-called ‘seeding grants’. A final selection from the 21 submissions was made during the Annual EAU Congress in Copenhagen, last...
ERUS18: A push for enhanced patient recovery programme
The fifteenth annual meeting of the EAU Robotic Urology Section is taking place this September in Marseille, on France’s Mediterranean coast. We spoke to Dr. Jochen Walz (Marseille, FR), chairman of the ERUS18 Local Organising Committee and de facto...
Introducing a new journal: European Urology Oncology
The EAU is gearing up to offer a new scientific journal besides the established titles of European Urology and European Urology Focus. We spoke to the Editor-in-Chief of European Urology Oncology, Prof. Alberto Briganti (IT) about the journal’s mission,...
Young Urologists Competition presents fresh insights at BALTIC17
Fresh perspectives on various urological conditions were presented during the highly-anticipated Young Urologists Competition session of the 4th Baltic Meeting in conjunction with the EAU (BALTIC17) held for the second time in Vilnius, Lithuania. Chaired by Professors Bob Djavan (AT) and Michel...
BALTIC17 looks into best practices in uro-oncology
Vilnius welcomed more than 250 participants to the 4th Baltic Meeting (BALTIC17) with the opening session focusing on best and current practices in diagnosing and managing urological cancers particularly the role of biopsy techniques, imaging tools, quality of life...
EMUC16: Refined patient selection is crucial to improve impact of chemotherapy for bladder cancer patients
Bladder cancer, widely considered as an underfunded area in urological malignancies, requires a more refined clinical staging if patients are to optimally benefit from treatment such as neoadjuvant chemotherapy (NAC). The first step in improving the impact of NAC...